What does the company do?
Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson’s disease and respiratory products. Teva’s active pharmaceutical ingredient business provides vertical integration to Teva’s own pharmaceutical production and sells to third party manufacturers. The Company’s global operations are conducted in North America, Europe, Latin America, Asia and Israel. Teva has operations in more than 60 countries, as well as 38 finished dosage pharmaceutical manufacturing sites in 17 countries, 20 generic research and development centers operating mostly within certain manufacturing sites and 20 API manufacturing sites around the world. In January 2009, Phibro Animal Health Corporation completed the acquisition of the Abic Animal Health business from the Company.
How much does the company sell and earn?
Investors need to know how much stuff or services a company sells, and how much of that total it keeps as income (or profit) to grow its business or return to shareholders. The more of each, the better. In general, look for companies that sell and earn more than peers.
- Teva one-year sales: 12.95 Bil.
Difference from the average for the Drug Manufacturers - Other group: 78.53% - Teva one-year income: 933.00 Mil.
Difference from the average for the Drug Manufacturers - Other group: 0.74%| Sales & Income (past 12 months) | Company | Industry |
|---|
| Sales | 12.95 Bil | 7.25 Bil | | Income | 933.00 Mil | 926.18 Mil |
How fast is the company growing?
- Teva one-year sales growth: 22.60%.
Difference from the average for the Drug Manufacturers - Other group: -3.30 pct. pts. - Teva one-year income growth: 24.40%.
Difference from the average for the Drug Manufacturers - Other group: -119.90 pct. pts.| Sales & Income Growth (past 12 months) | Company | Industry |
|---|
| Sales Growth | 22.60% | 25.90% | | Income Growth | 24.40% | 144.30% |
How profitable is the company?
Investors prefer companies that increase profit margins -- the percentage of sales that they keep -- every year. This is accomplished either by lowering expenses or raising prices. Look for companies that consistently find ways to squeeze more profits out of sales than their peers.
- Teva one-year net profit margin: 7.4%
Difference from the company's 5-year average net profit margin: -4.3 pct. pts.
| Net profit margins (%) |
|---|
| Company | 7.4% | | Company 5-Yr Avg. | 11.7% | | Industry | -20.0% |
How is the company's financial health?
The debt/equity ratio shows how much a firm has borrowed as a percentage of its stock equity. The lower, the better.
- Teva debt/equity ratio: 0.30.
Difference from the average for the Drug Manufacturers - Other group: 7.14%.
| | Company | Industry |
|---|
| Debt/equity ratio | 0.30 | 0.28 |
|
Recent News